On July 18, 2022, Venable attorney Ha Kung Wong co-authored "The Trouble with IP for Digital Health and Precision Medicine" in Center for Biosimilars. The following is an excerpt:
Precision medicine is changing the treatment landscape for countless patients, but with the transformational advances come a host of intellectual property (IP) issues that must be overcome to ensure the continued evolution of these life changing technologies. With a focus on digital health, we will discuss what precision medicine is and the IP hurdles it faces, such as patent subject matter eligibility, proving infringement, and software licensing.
Click here to access the article.